BiotechTubeBiotechTube
Byondis

Byondis

Pre-clinical
Nijmegen, NetherlandsFounded 2012byondis.com

Byondis develops antibody-drug conjugates and other targeted therapies for cancer treatment.

Founded
2012
Focus
AntibodiesBiologics

About

Byondis develops antibody-drug conjugates and other targeted therapies for cancer treatment.

Funding History

3

Total raised: $105M

Debt$25MEuropean Investment BankMay 15, 2021
Series B$50MBOM CapitalSep 15, 2020
Series A$30MBOM Brabant VenturesMar 15, 2018

Company Info

TypePrivate
Founded2012
LocationNijmegen, Netherlands
StagePre-clinical

Contact

byondis.com

Sectors

Biologics / Biosimilars
SIMILAR COMPANIES
2-BBB Medicines
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile